PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.

Patrik FazioCheryl J Fitzer-AttasLadislav MrzljakJuliana BronzovaSangram NagJohn H WarnerBernhard LandwehrmeyerNabil Al-TawilChrister HalldinAnton ForsbergJennifer WareValentina DildaAndrew WoodCristina SampaioAndrea Varronenull null

Published in: Movement disorders : official journal of the Movement Disorder Society (2020)

[18 F]MNI-659 PET imaging is a biologically plausible biomarker of Huntington's disease progression that is more sensitive than the dopamine-receptor and volumetric methods currently used. © 2020 International Parkinson and Movement Disorder Society.

Keyphrases

pet imaging
positron emission tomography
computed tomography
pet ct
metabolic syndrome